A prototype bandage designed to actively monitor the condition of chronic wounds and deliver appropriate drug treatments to improve the chances of healing has been developed by the researchers at Tufts University (TU). While the lab-tested bandages remain to be assessed in a clinical context, the research is aimed at transforming bandaging from a traditionally passive treatment into a more active paradigm to address a persistent and difficult medical challenge. Chronic skin wounds from burns, diabetes (lat. Diabetes Mellitus), and other medical conditions can overwhelm the regenerative capabilities of the skin and often lead to persistent infections (lat. Infectio) and amputations.